David Levy, MD, FRCP INTRODUCTION Every day many patients with established or newly diagnosed diabetes pass through emergency departments. Few require admission, but all need careful evaluation and management: emergencies in diabetes can develop rapidly, and they carry a risk of mortality. Deciding who needs admission requires clinical skill and experience. …
Read More »Are DPP-4 Inhibitors Really a Risk Factor for Pneumonia?
An international team of researchers examined a cohort of nearly 50,000 patients to find out…. Dipeptidyl peptidase-4 (DPP-4) inhibitors may alter the immune response and increase the risk of infections, but evidence for this association is limited. The United Kingdom Clinical Practice Research Datalink (CPRD) and the Hospital Episodes Statistics …
Read More »Handbook of Diabetes, 4th Ed., Excerpt #28: Diabetes in Old Age
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP There is a steep age-related increase in the prevalence of diabetes and impaired glucose tolerance which applies equally to both sexes. Overall, diabetes prevalence is higher in men, but there are more women with diabetes. In developing countries, most people with diabetes …
Read More »Early Insulin Therapy Makes an Impact
Improved glycemic control can reduce A1c, medical costs and complications… According to a new study, early introduction of insulin could save money, help more patients reach A1c goals and decrease diabetes-related complications and mortality. Currently, insulin therapy for persons with type 2 diabetes is traditionally added to an anti-hyperglycemic regimen …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 11
In this week’s Homerun Slides, we cover the importance of the Incretin Effect with an examination of the mechanisms of action of GLP-1 agonist and DPP-4 inhibitor drugs including the cardioprotective aspects of these medications…. To download these slides in PowerPoint (.ppt) format, use this link: Diabetes Mellitus 101 for Cardiologists, Part 11 …
Read More »The Efficacy of Saxagliptin in Combination Therapy
Saxagliptin shows improved glycemic control when added to other classes of medications in type 2 diabetes patients… Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by extending the half-life of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). The medication can be used as monotherapy or in combination with …
Read More »DPP-4 Inhibitors in Combination with Insulin Therapy for Type 2 Diabetes Patients
The addition of a DPP-4 inhibitor decreased HbA1C while not requiring an increase in insulin, and subjects remained weight neutral without experiencing an increase in hypoglycemic events… Currently approved dipeptidyl peptidase-4 (DPP-4) inhibitors include alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin. DPP-4 inhibitors work by enhancing glucose dependent insulin secretion and …
Read More »Metformin Is Best Initial Oral Drug for Lowering Glucose Levels in Diabetes Patients
Metformin, sulfonylureas, thiazolidinedione, and DPP-4 inhibitors were compared to evaluate the effects on the time to subsequent treatment… There are many classes of oral drugs used for diabetes therapy, but there is a lack of evidence as to which drug is best for use as initial therapy. Most patients diagnosed …
Read More »Handbook of Diabetes, 4th Edition, Excerpt #12: Hypoglycemia
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Etiology and clinical presentation Hypoglycemia is a common side effect of treatment with insulin and oral antidiabetic drugs, especially sulphonylureas, and is a major factor preventing patients with type 1 and 2 diabetes from achieving near normoglycemia. The brain is dependent …
Read More »No Risk Seen of CHF with Incretin-Based Drugs in T2DM
A large study in the UK looked at the long-term effects of GLP-1 and DPP-4 therapy on patients’ risk of congestive heart failure….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.